Both proteins have been implicated in cancer progression in their dependence on ADAM10, making it tempting to speculate that these proteins may contribute to mediating the ADAM10 phenotype in BCP-ALL [62–64]. This evidence concerns the gene ADAM10 and acute lymphoblastic leukemia.